Despite soaring global demand for healthcare, the challenge of profitably developing treatments has never been greater or more ethically complex. Can pharma giants strike the right balance?
Recent insights
22 4月 2026
Cross Examining Cyber: Conversations with cyber leaders
20 4月 2026
FDA pushes for broader powers to curb misleading direct to consumer drug advertising
1 4月 2026
UPC Structure – local, regional and central divisions and Court of Appeal, Judges & Languages
19 3月 2026
Pharmaceuticals: Deals revival
19 3月 2026
Snapshot: Key European pharma regulatory, IP and competition developments from 2025 for the pharmaceutical sector
12 3月 2026
Pharma: Key UK legal developments from 2025
12 2月 2026
UPC Court Fees
12 2月 2026
Corporate Crime 360: Your complete guide to APAC trends in 2026
11 2月 2026
2026 Employment and Workplace Relations in Australia Legal Guide
15 1月 2026
Two and a half years of the UPC – Trends and turning points
19 12月 2025
Treasury Updates Merger Rules
19 12月 2025
A new era for EU pharmaceutical law: political agreement reached on the reform
Key contacts
Alan Montgomery
Partner, Head of Pharmaceuticals Sector, Chair of India Group, London and India Group
Chris Parker KC
Partner, Head of Pharmaceuticals Sector, London and Africa Group
Natalie Bryce
Partner, Brisbane